The global oncology ecosystem continues to expand with the discovery of novel targets, scientific breakthroughs in both pharmaceuticals and devices and approvals of treatments for advanced cancers that are intended to bring improved outcomes for an increasing number of patients.

This report covers blockbuster drugs, key approvals by the FDA and EMA, ongoing clinical trials and trials to look out for, key actions taken by the regulatory body in the oncology area, and future trends in treatment and diagnostics.